Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia

NCT02993809 is registered in ClinicalTrials.gov with South China Research Center for Stem Cell and Regenerative Medicine as lead sponsor.

NCT NCT02993809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia
Lead sponsor
South China Research Center for Stem Cell and Regenerative Medicine
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2018
Completion date
Not reported
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, gangrene, ischemia, leg ulcer, peripheral vascular disease